Anglo–French Drugs & Industries Limited (AFDIL) is a pharmaceutical company established in 1923 and based in Bengaluru. The company is mainly engaged in the manufacturing of pharmaceutical formulations. Pharmaceutical formulation is a process in which different chemical substances including the active drug are mixed with each other to produce a final medicinal product.
Anglo–French Drugs & Industries Limited is one of the most prominent pharmaceutical companies recognized not only in India but also at a global level. Anglo-French Drugs & Industries Limited is the first company to manufacture single vitamin injections and a combination of B-complex vitamins in India.
The company focuses mainly on vitamins, sleep-inducing agents, antiepileptics and antioxidants, cold and cough preparations, protein food supplements, antibiotics, anti-inflammatory drugs, digestive enzymes, and calcium supplements.
Anglo–French Drugs & Industries Limited serves around 75,000 medical practitioners in India annually. The company has a well-distributed network of 24 clearing and forwarding agents and 1600 stockists. The products of Anglo-French Drugs & Industries Limited are available at over 50,000 stores in India. The company has a presence in 16 countries across Eastern Europe, South East Asia & Africa.
Equity shares of Anglo–French Drugs & Industries Limited are listed on the Metropolitan Stock Exchange of India (MSEI).
| Anglo-French Drugs & Industries Outstanding Shares: | 1233382 |
| Face Value of Anglo-French Drugs & Industries Unlisted Share: | Rs. 10 Per Equity Share |
| ISIN of Anglo-French Drugs & Industries Unlisted Share: | INE570E01016 |
| Lot Size of Anglo-French Drugs & Industries Unlisted Share: | 100 Shares |
| Anglo-French Drugs & Industries Share Price: | Best in Industry |
| PAN Number of Anglo-French Drugs & Industries: | AAACA9756E |
| GST Number of Anglo-French Drugs & Industries: | 29AAACA9756E1ZH |
|
CIN |
L24230KA1923PLC010205 |
|
Registration Date |
01 February 1923 |
|
Category/Sub-category of the Company |
Company limited by shares |
|
Address of the Registered office and contact details |
No.41, 3rd Cross, V Block, SSI Area, Rajajinagar, Bengaluru – 560010, Karnataka Telephone: 080-2315 6757 |
|
Name, Address, and Contact Details of Registrar and Transfer Agent, if any |
Canbank Computer Services Limited, J.P. Royale, 1st Floor, #218, 2nd Main Sampige Road, Malleswaram, Bengaluru-560003, Telephone: 080-23469661/62 |
|
Name and Description of main products/services |
NIC Code of the product/service |
% to the total turnover of the Company |
|
Manufacturing of Pharmaceutical Formulations |
21002 |
100% |
Mr. Abhay Kanoria (Chairman & Managing Director)
Mr. Uddhav Kanoria (President & Whole-time Director)
Mr. Nirbhay Kanoria (Whole-time Director)
Mr. Sanatkumar Manjunath Shirali (Independent Director)
Mr. Nalagath Ahmedali (Independent Director)
Mrs. Neha Gada (Independent Director)
Mr. Shashikant N More (Nominee Director)
Dr. Rajeshwar B Smarta (Additional Independent Director)
Mr. Rakesh P Kanyadi (Additional Non-Executive Director)
|
Name of the Company |
% of shares held |
|
Anglo-French Drugs & Industries Private Limited, Singapore |
100% |
|
S. No. |
Shareholders’ Name |
Number of shares |
% of total Shares of the company |
|
1 |
Promoter and promoter group |
834855 |
64.642 |
|
2 |
Public |
456645 |
35.358 |
|
Total |
12,91,500 |
100 |
Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability have helped India to manufacture pharma products at a very low cost.
The Indian healthcare market saw a 3 fold jump in terms of value. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19.
After the onset of COVID-19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.
FAQS ON ANGLO-FRENCH DRUGS AND INDUSTRIES UNLISTED STOCKS
In which sector does Anglo French Drugs & Industries Ltd work?
Anglo French Drugs & Industries Ltd works in the pharmaceutical sector.
Is Anglo Anglo-French Drugs & industries a profitable company?
Yes, anglo Anglo-French Drugs & industries is a profit-making company.
Explain the nature of the business of Anglo-French Drugs & Industries Ltd.
The company mainly focuses on vitamins, sleep-inducing agents, antiepileptics and antioxidants, cold and cough preparations
protein food supplements, antibiotics, anti - anti-inflammatory drugs, digestive enzymes, and calcium supplements.
What is the lot size of Anglo French Drugs & Industries Ltd shares?
The lot size is 100 shares
What is Anglo French Drugs & Industries Ltd share price today and how can I invest in it?
Anglo-French drugs & industries share price keeps changing regularly, to invest you can visit our website wwipl.com, or contact us
